DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 205 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2021. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $761,796 | +14.4% | 51,560 | +0.0% | 0.00% | – |
| Q2 2023 | $665,707 | +31.6% | 51,545 | -0.1% | 0.00% | – |
| Q1 2023 | $506,020 | +106.7% | 51,608 | +124.0% | 0.00% | – |
| Q4 2022 | $244,779 | +1.5% | 23,037 | -50.0% | 0.00% | – |
| Q3 2022 | $241,241 | -16.8% | 46,078 | +100.0% | 0.00% | – |
| Q2 2022 | $290,000 | +16.0% | 23,036 | +0.2% | 0.00% | – |
| Q1 2022 | $250,000 | -22.6% | 22,991 | +0.2% | 0.00% | – |
| Q4 2021 | $323,000 | +47.5% | 22,954 | +101.1% | 0.00% | – |
| Q3 2021 | $219,000 | – | 11,417 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital, LLC | 5,782,610 | $25,733,000 | 1.15% |
| Avidity Partners Management LP | 4,000,000 | $17,800,000 | 0.58% |
| PFM Health Sciences, LP | 2,936,990 | $13,070,000 | 0.46% |
| Rhenman & Partners Asset Management AB | 925,534 | $4,119,000 | 0.34% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,470,000 | $6,542,000 | 0.22% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $545,000 | 0.21% |
| Rock Springs Capital Management LP | 1,649,420 | $7,340,000 | 0.16% |
| FEDERATED HERMES, INC. | 11,946,800 | $53,163,000 | 0.11% |
| Virtus ETF Advisers LLC | 57,062 | $254,000 | 0.10% |
| GABLES CAPITAL MANAGEMENT INC. | 31,225 | $139,000 | 0.08% |